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Abstract
Background:  Understanding how an organism replicates and assembles a multi-segmented genome with fidelity
previously measured at 100% presents a model system for exploring questions involving genome assortment and RNA/
protein interactions in general. The virus family Reoviridae, containing nine genera and more than 200 members, are
unique in that they possess a segmented double-stranded (ds) RNA genome. Using reovirus as a model member of this
family, we have developed the only functional reverse genetics system for a member of this family with ten or more
genome segments.
Using this system, we have previously identified the flanking 5' sequences required by an engineered s2 ssRNA for
efficient incorporation into the genome of reovirus. The minimum 5' sequence retains 96 nucleotides and contains a
predicted sequence/structure element. Within these 96 nucleotides, we have identified three nucleotides A-U-U at
positions 79–81 that are essential for the incorporation of in vitro generated ssRNAs into new reovirus progeny viral
particles. The work presented here builds on these findings and presents the results of an analysis of the required 3'
flanking sequences of the s2 ssRNA.
Results: The minimum 3' sequence we localized retains 98 nucleotides of the wild type s2 ssRNA. These sequences do
not interact with the 5' sequences and modifications of the 5' sequences does not result in a change in the sequences
required at the 3' end of the engineered s2 ssRNA. Within the 3' sequence we discovered three regions that when
mutated prevent the ssRNA from being replicated to dsRNA and subsequently incorporated into progeny virions. Using
a series of substitutions we were able to obtain additional information about the sequences in these regions. We
demonstrate that the individual nucleotides from, 98 to 84, 68 to 59, and 28 to 1, are required in addition to the total
length of 98 nucleotides to direct an engineered reovirus ssRNA to be replicated to dsRNA and incorporated into a
progeny virion. Extensive analysis using a number of RNA structure-predication software programs revealed three
possible structures predicted to occur in all 10 reovirus ssRNAs but not predicted to contain conserved individual
nucleotides that we could probe further by using individual nucleotide substitutions. The presence of a conserved
structure would permit all ten ssRNAs to be identified and selected as a set, while unique nucleotides within the structure
would direct the set to contain 10 unique members.
Conclusion: This study completes the characterization and mapping of the 5' and 3' sequences required for an
engineered reovirus s2 ssRNA to be incorporated into an infectious progeny virus and establishes a firm foundation for
additional investigations into the assortment and encapsidation mechanism of all 10 ssRNAs into the dsRNA genome of
reovirus. As researchers build on this work and apply this system to additional reovirus genes and additional dsRNA
viruses, a complete model for genome assortment and replication for these viruses will emerge.
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Background
The name reovirus includes the acronym reo-(respiratory
enteric orphan), so designated because reovirions can be
isolated from the respiratory and intestinal tracts of both
warm and cold-blooded animals, but have not been asso-
ciated with specific clinical diseases. There are three major
mammalian reovirus serotypes: serotype 1, serotype 2,
and serotype 3 (ST1, ST2, ST3).
The genome of reovirus consists of ten unique segments
of double-stranded RNA [1]. The segments are classified
according to size. Three size classes exist: large (L) seg-
ments consist of about 3800 base pairs each, medium (M)
segments consist of about 2200 base pairs each, and small
(S) segments consisting of about 1100–1400 base pairs
each. Each virion contains three L (L1, L2, L3), three M
(M1, M2, M3), and four S (S1, S2, S3, S4) segments. Reo-
virions contain a transcriptase that transcribes the genome
segments, by way of a conservative mechanism, into
ssRNA molecules. These molecules are the (+) strand and
function as mRNA. Each of the virions' RNA transcripts
can code for the synthesis of at least one polypeptide.
Twelve reovirus-specific polypeptides are synthesized in
infected cells and are divided into three size classes: the
lambda (λ) class, containing the high molecular weight
polypeptides (λ1, λ2,  3), the mu (µ) class, containing
the intermediate size polypeptides (µ1, µ1c, µ2, µNS),
and the sigma (σ) class, containing the low molecular
weight polypeptides (σ1, σ1s, σ2, σNS, 3).
The dsRNA viruses are grouped into six families: the
Birnaviridae, Cystoviridae, Hypoviridae, Partitiviridae,
Reoviridae and Totiviridae. Within the family Reoviridae,
in addition to reovirus, extensive work on genome assort-
ment has been done with bluetongue virus [2-4] and rota-
virus [5-8]. What remains true for each of these viruses is
the lack of a complete explanation for how a multi-seg-
mented dsRNA virus is able to replicate, assort and pack-
age multiple RNA segments to yield progeny virus
particles with particle to PFU ratios less than 10 and for
reovirus measured by one researcher, approaching 1.0 [9].
All reovirus ssRNAs possess the tetranucleotide GCUA- at
their 5' ends and the pentanucleotide -UCAUC at the 3'
ends of their plus strands. This conservation of nucle-
otides is also present in the ssRNAs of the other members
of the Reoviridae family, with all the genome segments of
a specific virus possessing identical nucleotides at their 5'
and 3' termini, but with these nucleotides being different
from family to family.
This evolutionary conservation of the terminal nucle-
otides suggests a functional importance for these
sequences. Work with rotavirus has identified a possible
secondary structure in the rotavirus ssRNAs that involves
an interaction between the 5' and 3' ends of these RNA
molecules. This structure has been suggested to represent
a replication/packaging structure [5]. Although such a
structure may be possible for the reovirus ssRNA mole-
cules, we have been able to demonstrate a biologically
functional 5' sequence/structure [10] independent of the
3' sequence. We previously constructed a cDNA template
that can be transcribed in vitro or in vivo, by T7 RNA
polymerase, to yield an RNA transcript that possesses the
authentic 5' and 3' terminal sequences of the reovirus s2
mRNA found in vivo. When we began to examine the 5'
sequences we hypothesized that reovirus ssRNAs contain
both replication signals, signals that when absent or
mutated prevent the formation of a dsRNA copy of a
ssRNA, and encapsidation signals, signals that when
absent or mutated prevent the formation of infectious
progeny virus. As our 5' data demonstrated and now our
3' data corroborates, the two signals, if they exist can not
be distinguished independently from each other using our
system.
The 5' sequence retains 96 nucleotides of the wild type s2
ssRNA and a predicted sequence/structure element.
Within these 96 nucleotides, we identified three nucle-
otides A-U-U at positions 79–81 that are essential for the
incorporation of in vitro generated ssRNAs into new reo-
virus progeny viral particles.
This work identifies the 3' downstream flanking sequence
required to ensure incorporation of an engineered s2
ssRNA into the reovirus genome and, therefore, represents
a major step in the process of developing a reverse genetics
system for reovirus that supports the genetic engineering
of any reovirus genome segment. Unlike the 5' sequence
the 3' sequence contains three regions of conservation
within a total requirement of 98 nucleotides. Computer
secondary structure analysis has identified three possible
structures that are predicted to exist in the 3' 100 nucle-
otides of all 10 reovirus serotype 3 ssRNAs. Using this
work as a foundation we have engineered the m1 ssRNA
and are currently using it to test these predictions. Publi-
cation of the sequences at the 3' termini of the reovirus s2
ssRNA will immediately allow researchers to introduce
mutations into the S2 gene and protein σ2 to study the
function of this protein and its role in reovirus replication
and host cell interaction. Additionally, it will now be pos-
sible to use reovirus as a vaccine and gene vector by replac-
ing the CAT gene with a gene of interest, flanking the gene
with the 5' and 3' s2 sequences we have identified, and
replacing the wildtype S2 genome segment in reovirus
serotype 3. Researchers desiring to mutate any of the addi-
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Survey of the minimum 3' terminal s2 ssRNA nucleotides required to direct a ssRNA into the reovirus genome using 50-nucle- otide deletions, single-nucleotide deletions and nucleotide deletions using ssRNAs with extended 5' sequences Figure 1
Survey of the minimum 3' terminal s2 ssRNA nucleotides required to direct a ssRNA into the reovirus genome using 50-nucle-
otide deletions, single-nucleotide deletions and nucleotide deletions using ssRNAs with extended 5' sequences. At the top, are 
the sequences of the 5' nucleotides of the ssRNAs produced using the T7 RNA polymerase promoter and cDNA template 
pS2CAT198 and pS2CAT96. The top two sequences include the first 18 nucleotides of the CAT coding sequence but do not 
show the 3' end of the ssRNA. The 3' sequence of these ssRNAs is shown in its entirety from the CAT stop codon to the 
authentic reovirus 3' terminus directly below the 5' ssRNA sequences. A line connects the last retained s2 nucleotide in the 
displayed sequence to the named cDNA plasmid, below which are displayed autoradiogram panels. Within each panel, the 
ssRNA, dsRNA and CAT dsRNA panels are Northerns analyzing RNA extracted from cells lipofected 12 hours earlier with 9 
wildtype ssRNAs and the ssRNA obtained following transcription of the indicated cDNA template. The fourth and bottom 
panel of each set is an autoradiogram generated by in vivo labeling with 32P of the dsRNA genome segments of an isolated 
progeny virus containing the indicated mutated-S2 dsRNA. Progeny virus generated following lipofection was first triple-plaque 
purified. Deletions were initially made in blocks of 50 nucleotides. Based on the sequences required to incorporate a ssRNA 
into a reovirus using the ssRNAs generated from these templates, additional cDNA templates were constructed deleting ten, 
five and individual nucleotides until the minimal 3' sequence had been determined. Left and center panels. To test the possibility 
that increasing the 5' s2 sequence from 96 to 198 nucleotides might reduce the length of the 3' sequence required, a number of 
the 3' deleted cDNA templates were altered to include a the 198 5' sequence and retested. The ability to incorporate these 
ssRNAs into the genomes of reoviruses is summarized in the right panel. As described in the Materials and Methods, all ssR-
NAs were sequenced/analyzed to confirm the 5' and 3' ends of these RNAs.
Sequential 3’ deletions of pS2CAT198 and pS2CAT96 ssRNAs
5’
(1) ST3 S2 5’ untranslated     S2 start    198     CAT
GCUAUUCGCUGGUCAGUU AUG GCU CGC GCU GCG UUC CUA UUC AAG ACU GUU GGG UUU GGU GGU CUG CAA AAU GUG CCA AUU AAC GAC GAA CUA UCU UCA CAU CUA CUC CGA GCU GGU AAU UCA CCA UGG CAG UUA ACA CAG UUU UUA GAC UGG AUA AGC CUU GGG AGG GGU UUA GCU ACA UCG GCU CUC GUU CCG ACG ACG GAU CCG AGA UUU
5’
(1) ST3 S2 5’ untranslated     S2 start  96   CAT
GCUAUUCGCUGGUCAGUU AUG GCU CGC GCU GCG UUC CUA UUC AAG ACU GUU GGG UUU GGU GGU CUG CAA AAU GUG CCA AUU AAC GAC GAA CUA UCU    ACG GAU CCG AGA UUU
5’                  CAT stop                                                                                  S2 (284  to 3’ terminus)                   250                     200                      150
CUA CGC CUG AAU AAG UGA UAA UAAGCGGAUGAAUGGCAGAAAUUCGGAUCCAAGAUCUCGAGACGCGAUGGUGUCAUGACCCAAGCUCAGCAGAAUCAAGUUGAAGCGUUGGCAGAUCAGACUCAACAGUUUAAGAGGACAAGCUCGAAACGUGGGCGAGAGAAGACGAUCAAUAUAAUCAGGCUCAUCCCAACUCCACAAUGUUCCGUACGAAACCAUUUACGAAUGCGCAAU
                                                 G
                                                   G
                                                   G
3’                                                  G
    GAGGGAAUCGGAUGGCUUCAUCGGGUCCAGCCUGGCGCUCCUCCACCUCUACGGUACGGCUGGG  CUACUUACACACCAGUCAGCACUCCACACACCCCCCUGGGGGAGUGAGGUUCUGCUAGUCUAUUCCCGACGUUAGCGCCGUGAUCAGCGGGGGCAUAAUGGAGCA
HDV- ribozyme   S2 (3’ terminus)   31   50               75                100Virology Journal 2006, 3:1 http://www.virologyj.com/content/3/1/1
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tional nine reovirus genes of serotype 3 or the genes of
serotypes 1 or 2 can use these results to extend this system
to these viruses. We have now completed construction of
an M1-CAT reovirus using the methods and findings pre-
sented in this paper (unpublished results).
Results and Discussion
Construction of s2-CAT cDNA templates and transcription 
to yield the engineered ssRNAs
The purpose of this investigation was to determine the 3'
s2 ssRNA sequence required for incorporation into a sta-
Detection of virus-generation intermediates using the ssRNAs generated from the sequence-substitution cDNA templates out- lined in Table 2, using the reovirus infectious RNA system Figure 2
Detection of virus-generation intermediates using the ssRNAs generated from the sequence-substitution cDNA templates out-
lined in Table 2, using the reovirus infectious RNA system. The ssRNA (in the top panel), the dsRNA (in the next panel down) 
and the CAT dsRNA (the third panel down) are shown utilizing Northerns analyzing RNA extracted from cells lipofected 12 
hours earlier with 9 wildtype ssRNAs and the ssRNA obtained following transcription of the indicated cDNA template. The 
fourth and bottom panel is an autoradiogram following SDS-PAGE generated by in vivo labeling with 32P of the dsRNA genome 
segments of an isolated progeny virus containing the indicated mutated-S2 dsRNA. Progeny virus generated following lipofec-
tion was first triple-plaque purified.
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5’
(1) ST3 S2 5’ untranslated     S2 start  96   CAT
GCUAUUCGCUGGUCAGUU AUG GCU CGC GCU GCG UUC CUA UUC AAG ACU GUU GGG UUU GGU GGU CUG CAA AAU GUG CCA AUU AAC GAC GAA CUA UCU    ACG GAU CCG AGA UUU
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ble recombinant reovirus utilizing our marker rescue sys-
tem [10-12]. We have previously demonstrated
incorporation of an engineered s2 ssRNA that retained 96
nucleotides from the s2 ssRNA 5' end and 284 nucleotides
from the s2 ssRNA 3' end into the reovirus genome
[10,12]. In this study, we conducted an analysis of the 284
3' terminal nucleotides of this engineered reovirus s2
ssRNA. To accomplish this, we have generated a large col-
lection of cDNA templates based on our original tem-
plates, pS2CAT198 and pS2CAT96 [10,12]. See Figure 1.
The parent plasmid contains a T7 polymerase promoter
placed at the 5' end of the construct and the T7 terminator
at the 3' end. The ssRNA generated from this cDNA is
1234 nucleotides long, 97 nucleotides shorter than the wt
s2 RNA. It encodes a σ2-CAT fusion protein that possesses
66 σ2 AAs at its N-terminus and does not express protein
σ2 function, but demonstrates CAT catalytic activity
[10,12]. We use the fact that most of our recombinant
viruses demonstrate CAT activity as a first screen to reduce
the possibility that we have selected a serotype 2 helper
virus rather than a recombinant serotype 3 virus. We also
screen by SDS-PAGE analysis of the genome segments and
all selected viruses are sequenced to confirm the organiza-
tion of the S2 genome segment before proceeding. The
remaining cDNA templates used in this study were gener-
ated using site-directed mutagenesis to delete the indi-
cated s2 3'sequences from the pS2CAT198 or pS2CAT96
cDNA template. See Figures 1 and 2.
3' S2 sequences required for ssRNA incorporation
From our earlier work, we knew that 96 nucleotides from
the wt s2ssRNA 5' end and 284 nucleotides from the 3'
end are sufficient to enable a ssRNA to be incorporated as
a dsRNA genome segment into the reovirus genome. As
we have previously noted and can be seen in Figure 1, the
s2CAT198 dsRNA migrates slower than the ST3 wt s2
dsRNA, although it is 97 nucleotides shorter [10,12]. This
is not unexpected, as a number of reovirus dsRNA seg-
ments do not migrate in SDS-PAGE gels according to
actual size.
To determine the minimal 3' s2 ssRNA sequence that
retains this activity, we began by reducing the 3' sequence
in steps of 50 nucleotides (ssRNAs S2CAT3a-f) from
nucleotide 284. The ssRNAs generated from these cDNA
templates were lipofected into cells supplying functional
σ2 protein, using the reovirus marker rescue system
described in the Materials and Methods section. We then
examined the ssRNA, dsRNA, and CAT-dsRNA using
Northerns, 12 hours following lipofection. Thirty-six
hours later, samples were harvested and plaque assays per-
Table 1: Sequential 3' deletions of pS2CAT198 and pS2CAT96 ssRNAs
cDNA Clone Length of 5' S2 
sequence
Length of 3' S2 
sequence
CAT Activity 
[pg/ml]
ssRNA detected dsRNA 
detected
Engineered 
RNA 
incorporated 
into infectious 
virus
pS2CAT198 198 284 64 + + +
pS2CAT96 96 284 64 + + +
pS2CAT3a 96 250 64 + + +
pS2CAT3b 96 200 32 + + +
pS2CAT3c 96 150 32 + + +
pS2CAT3d 96 100 64 + + +
pS2CAT3e 96 50 64 + - -
pS2CAT3f 96 31 32 + - -
pS2CAT3g 96 75 64 + - -
pS2CAT3h 96 80 64 + - -
pS2CAT3i 96 90 32 + - -
pS2CAT3j 96 95 32 + - -
pS2CAT3k 96 96 64 + - -
pS2CAT3l 96 97 32 + - -
pS2CAT3m 96 98 64 + + +
pS2CAT3n 96 99 64 + + +
pS2CAT198l 198 97 64 + - -
pS2CAT198k 198 96 64 + - -
pS2CAT198j 198 95 32 + - -
pS2CAT198i 198 90 64 + - -
pS2CAT198h 198 80 64 + - -
pS2CAT198g 198 75 32 + - -
pS2CAT198e 198 50 32 + - -
pS2CAT198f 198 31 32 + - -Virology Journal 2006, 3:1 http://www.virologyj.com/content/3/1/1
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formed as described. Generated viruses were isolated
using plaque assays on L-ST3.S2 cell monolayers, and
replaqued three times for purity. The dsRNA genome seg-
ments of individual purified viruses were labeled in vivo
with  32P following infection of L-ST3.S2 cells and ana-
lyzed by SDS-PAGE. Autoradiograms of these cells dem-
onstrating migration rates/patterns of individual viruses
are shown in the bottom panels for each deletion. We
continued with these deletions, until we reached a 3'
length of 31 nucleotides. Figure 1 and Table 1.
Based on our results, the next series of deletions we made
focused on the sequences between nucleotides 100 and
50. The ssRNAs, S2CAT3g-n were used to identify the min-
imum s2 sequence required of a ssRNA to be incorporated
into a virus particle. See Figure 1. These deletions gener-
ated a ssRNA retaining 96 5' and 98 3' nucleotides from
the wildtype s2ssRNA, and reduced from 1331 to 946 96
(s2-5') + 752 (CAT) + 98 (s2-3') nucleotides that are
assorted, replicated to dsRNA and incorporated into a
progeny virus. These results are summarized in Table 1.
Support from additional 5' sequences
To explore the possibility that interactions could be taking
place between the 5' and 3' sequences, we altered the 5'
sequences of some of our 3' constructs. We examined the
possibility that extending the 5' sequence from 96 to 198
nucleotides might "rescue" ssRNAs with 3' sequences less
than the 98 we had just demonstrated. Summarized in
Table 1 and Figure 1 using the cDNA templates
pS2CAT198l-f we retested our previous 3' deletions, now
with a 5' leader sequence of 198 rather than 96 nucle-
otides. As can be seen from our results, we were unable to
"rescue" any ssRNAs with a 3' sequence of less than 98
nucleotides with a ssRNA containing 198 5' nucleotides.
Nucleotide substitution within the required 98 nucleotides
We then generated a series of cDNA templates with 10
base substitutions of the 98 nucleotide 3' sequence we
had identified. The results of these substitutions are sum-
marized in Table 2 and shown in Figure 2. Scanning using
a series of 10-base substitution sequences, we identified
three regions in the 3' sequence that when substituted
resulted in a loss of dsRNA synthesis and no progeny virus
was produced. The first region was from nucleotides 98 to
79, clones pS2CATsub1 and pS2CATsub2. The second
from nucleotides 68 to 59, clone pS2CATsub4. The third
from nucleotides 28 to 1, clones pS2CATsub8,
pS2CATsub9 and pS2CATsub10.
Using a series of 5 base substitutions we were able to
obtain additional information about the sequences in
these regions. Using ssRNA generated from the plasmids
pS2CATsub11-21, Table 2 and Figure 2, we demonstrated
Table 2: Sequence substitution of the 3' sequences of pS2CAT96
cDNA Clone Length of 5' 
S2 sequence
Length of 3' 
S2 sequence
Substituted 
Sequence
CAT Activity 
[pg/ml]
ssRNA 
detected
dsRNA 
detected
Engineered 
RNA 
incorporated 
into infectious 
virus
pS2CAT3m 96 98 none 64 + + +
pS2CATsub1 96 98 98-89 64 + - -
pS2CATsub2 96 98 88-79 64 + - -
pS2CATsub3 96 98 78-69 32 + + +
pS2CATsub4 96 98 68-59 32 + - -
pS2CATsub5 96 98 58-49 64 + + +
pS2CATsub6 96 98 48-39 64 + + +
pS2CATsub7 96 98 38-29 32 + + +
pS2CATsub8 96 98 28-19 32 + - -
pS2CATsub9 96 98 18-9 64 + - -
pS2CATsub10 96 98 8-1 32 + - -
pS2CATsub11 96 98 98-94 64 + - -
pS2CATsub12 96 98 93-89 64 + - -
pS2CATsub13 96 98 88-84 64 + - -
pS2CATsub14 96 98 83-79 64 + + +
pS2CATsub15 96 98 68-64 64 + - -
pS2CATsub16 96 98 63-59 64 + - -
pS2CATsub17 96 98 28-24 32 + - -
pS2CATsub18 96 98 23-19 64 + - -
pS2CATsub19 96 98 18-14 64 + - -
pS2CATsub20 96 98 13-9 32 + - -
pS2CATsub21 96 98 8-4 64 + - -Virology Journal 2006, 3:1 http://www.virologyj.com/content/3/1/1
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that the individual nucleotides from 98 to 84, 68 to 59
and 28 to 1 are required in addition to the total length of
98 nucleotides to direct an engineered reovirus ssRNA to
be replicated to dsRNA and incorporated into a progeny
virion. Extensive analysis using a number of RNA struc-
ture-predication software programs, did not predict a
structure that we could probe further by using individual
nucleotide substitutions.
Prediction of possible secondary structures in the 3' 
sequences
Secondary structures predicted to exist in the last 100
nucleotides of the 3' ends of all ten reovirus serotype 3
ssRNAs using FOLDALIGN® [13] are shown in Figure 3.
We have continued our analysis of the reovirus s2 ssRNA
to identify the sequences required to direct this RNA to be
replicated to dsRNA and incorporated into the genome of
reovirus. An analysis of the 5' sequences revealed a possi-
ble stem-loop structure and a requirement for 96 nucle-
otides retained from the wildtype s2 ssRNA [10]. These 96
nucleotides and 284 from the wt s2 at the 3' end of an
engineered ssRNA are sufficient to direct incorporation of
an s2 ssRNA into the reovirus serotype 3 genome. The
required 3' s2 sequences have now been reduced to 98
nucleotides, a length similar to that required at the 5' end,
but the overall organization of the 3' sequences appears to
be quite distinct from that found in the 5' sequence.
We have identified three regions within a required total
sequence consisting of 98 s2 3' terminal nucleotides, that
when coupled with an additional 96 s2 5' terminal nucle-
otides are required to direct the incorporation of this RNA
into an infectious reovirus. The three regions include
nucleotides 98 to 84, 68 to 59, and 28 to 1. These findings
are summarized in Figure 4.
When we replaced the nucleotides contained within these
regions with a random sequence 5' AGUCGUAUGC or
shortened versions of this sequence, we abolished the
ability of the ssRNA to be incorporated as a dsRNA into
the reovirus genome.
Using the RNA structure/alignment programs, RNAStruc-
ture, Vienna RNA Package, Mfold, PKnots, RNABOB and
RNACAD we have been unable to obtain a predicted
structure that fits our data and is also predicted to exist in
the remaining 9 reovirus ssRNAs.
We have examined the possibility that the conserved 3'
region may interact with the 5' sequence we have identi-
fied. To date we have been unable to identify such a struc-
ture using currently available RNA structure prediction
software. Such an interaction has been proposed to func-
tion in rotavirus assembly and replication [14]. Our future
examination of the sequences required in additional reo-
virus ssRNAs should provide the necessary data to explore
such an interaction.
For reovirus to assort and assemble its ten segment
genome we hypothesize that at least two types of signals
exist; signals(s) that permit the RNA polymerase to bind
and initiate dsRNA synthesis, and signals(s) that permit
for the differentiation of each individual ssRNA as a
unique member of a set of 10 RNAs. This study identifies
the minimal RNA sequence at the 3'terminus required for
an engineered ssRNA to be incorporated into the reovirus
genome and together with our 5' data the sequences
required of a ssRNA to be replicated to dsRNA and assem-
bled into the reovirus genome. To elucidate the signals
common and distinct in all 10 ssRNAs we are conducting
a similar analysis of the 5' and 3' sequences of the reovirus
l1 and m1 ssRNAs. With the data from these genes we
should be able to identify the biological signals in the
remaining seven ssRNAs and construct a model for
genome assortment and replication.
Using the minimal 5' and 3' sequences we have now iden-
tified for the s2 ssRNA, it is possible to use this marker res-
Ball and stick representation of three secondary structures  predicted, using FOLDALIGN®, to exist in the 3' terminal  100 nucleotides of all 10 reovirus ssRNAs Figure 3
Ball and stick representation of three secondary structures 
predicted, using FOLDALIGN®, to exist in the 3' terminal 
100 nucleotides of all 10 reovirus ssRNAs. Individual nucle-
otides present at each position in each of the 10 reovirus 
ssRNAs are shown in the table below the figure.Virology Journal 2006, 3:1 http://www.virologyj.com/content/3/1/1
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cue system to introduce engineered mutations into the
reovirus serotype 3 S2 genome segment, isolate an infec-
tious mutant virus, and use this virus to address structure/
function questions of the S2 gene and its gene product
sigma 2 in vivo. In addition, at least 752 nucleotides can
now be engineered into the S2 gene to produce a recom-
binant virus expressing an engineered protein of 250
amino acids. Reovirus can now be used to express small
proteins for purification and/or vaccine development.
Extension of these studies to larger genes should expand
the effectiveness of this reovirus system.
Methods
Virus and cell lines
Reovirus ST3 strain Dearing and reovirus ST2 strain Jones
were used. Both were grown in L929 mouse fibroblasts in
MEM or RPMI supplemented with 5% FBS. The recom-
binant viruses containing the CAT gene (ST3.S2.CAT)
were grown in L929 cells transformed with pHβ APr-1-
neo [15] that contained ST3 S2 cDNA under the control of
the human β-~actin promoter. The transformed cells, L-
ST3.S2 cells, expressed protein σ2 at levels that were suffi-
cient to rescue tsC 447 [16-18], a ST3 virus mutant with a
ts mutation in the S2 genome segment, and support
growth of recombinant CAT-containing reoviruses
[10,12].
Engineering of reovirus s2 cDNA
As previously demonstrated, we can incorporate an engi-
neered reovirus s2 ssRNA into the reovirus genome as a
stable dsRNA genome segment [10,12]. In this work, we
deleted an internal 848 nucleotides from the wild type s2
sequence and replaced this with the CAT gene coding
sequence (752 bp). This allowed us to distinguish
between the wt s2 RNA and our engineered s2 RNA, both
by sequence analysis and functional CAT activity. We have
used this plasmid template to map the 5' sequences of the
s2 ssRNA required to direct this ssRNA to be incorporated
into a reovirus (6).
This template can be transcribed by T7 RNA polymerase to
yield an RNA transcript that possesses 5' and 3' terminal
sequences as authentic S2 RNA. The 5'-terminal S2
sequence ending at nucleotide 198 was fused, in frame, to
the CAT gene coding sequence [12]. The 3' terminus of the
CAT sequence was fused to the 3' S2 sequence, beginning
at bp 1047 (of the wild type s2 RNA); and the 3' terminus
of the S2 sequence, including the untranslated sequence,
was fused to the Hepatitis Delta Virus (HDV) ribozyme
sequence. Transcription by T7 RNA polymerase was termi-
nated with the T7 terminator sequence located 3' of this
construct. Transcription of this construction yielded an
RNA that contained the 198 5' nucleotides of s2 RNA
fused in frame to the CAT mRNA sequence followed by
the 284 3' terminal nucleotides of s2 RNA. This was
achieved by inserting the HDV ribozyme sequence in such
a way that when the ribozyme underwent auto-cleavage, it
left a terminal C at the 3' terminus. As a result, the 3' ter-
minal sequence of the transcript was the authentic reovi-
rus RNA 3' terminal sequence -UCAUC. Recloning and
subsequent sequencing and cleavage analysis confirmed
the authenticity of the 5' and 3' terminal sequences [12].
The pS2CAT198 construct was transcribed in vitro using
T7 RNA polymerase and the transcript was capped using
m7 GpppG (Promega) to yield s2-CAT mRNA. It was
translated in vitro using a rabbit reticulocyte lysate system
(Promega) and the lysate was found to contain CAT activ-
ity (CAT-ELISA, Boehringer Mannheim Corporation).
Mutagenesis of 3' s2 sequences down stream of the CAT 
gene in construct pS2CAT198 and pS2CAT96
Sequential deletion and mutagenesis of the 3' 284 nucle-
otides was carried out using GeneEditor™ by Promega
(#Q9280). This system uses antibiotic selection to obtain
a high frequency of mutants. Selection Oligonucleotides
provided with the GeneEditor™ System encode mutations
that alter the ampicillin resistance gene, creating a new
additional resistance to the GeneEditor™ Antibiotic Selec-
tion Mix. As directed by the manufacturer, we annealed
the selection oligonucleotide to our pS2CAT198 double-
stranded DNA template at the same time as a mutagenic
oligonucleotide. Subsequent synthesis and ligation of the
mutant strand links the two oligonucleotides. The muta-
genic oligonucleotides we selected were all 50 or more
nucleotides in length, 25 nucleotides matching the 3' S2
Three regions, nucleotides 98 to 84, 68 to 59, and 28 to 1, that when coupled with an additional 96 s2 5' terminal nucleotides  are required to direct the incorporation of this RNA into an infectious reovirus Figure 4
Three regions, nucleotides 98 to 84, 68 to 59, and 28 to 1, that when coupled with an additional 96 s2 5' terminal nucleotides 
are required to direct the incorporation of this RNA into an infectious reovirus.Virology Journal 2006, 3:1 http://www.virologyj.com/content/3/1/1
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and/or CAT nucleotide sequence depending upon the
location of the sequence we wished to retain, and 25
nucleotides matching the HDV-ribozyme nucleotide
sequence. Using 25 perfectly matched nucleotides on each
side of the mismatched sequence we wished to loop-out
and remove, we were able to remove nucleotides from the
original pS2CAT198 sequence. For example, the sequence
of the mutagenic oligonucleotide used to delete 50 nucle-
otides from pS2CAT96 to yield pS2CAT3b (Table 1) was;
5'GGCAGAAATTCGGATCCAAGATCTCCTCGAAACGTG
GGCGAGAGAAGACG3. To replace the nucleotides in the
plasmids generated from pS2CAT3m to yield templates
such as pS2CATsub1 (Table 2) the mutagenic oligonucle-
otide was 60 nucleotides in length. For pS2CATsub1 the
oligonucleotide contained 25 nucleotides matching
pS2CATm sequences flanking 10 nucleotides that would
be substituted for the wildtype sequences as summarized
in Table 2 and shown in Figure 2.
Removal of wt s2 RNA
Wild type s2 RNA was removed from the mixture of ten
ssRNA species as previously described [19]. The DNA oli-
gonucleotide selected for this purpose was complemen-
tary to nucleotides 937–949; and 10 pmoles were added
to 2 pmoles of s2 RNA. After hybridization, the mixture
was treated with RNAse H for 20 min. The RNA was
extracted three times with phenol/chloroform and precip-
itated with sodium acetate. Degradation of the s2 RNA
was confirmed by gel electrophoresis of both the RNA and
its translation products. The set of nine ssRNAs was sup-
plemented with the indicated s2-CAT RNAs and the
resulting mixture was lipofected into L-ST3.S2 cells that
were then infected with ST2 virus [11].
The reovirus marker rescue system
The system was used as described [10-12], but modified to
use L-ST3.S2 cells that express functional σ2 protein in
place of L929 cells. ST3 capped and methylated mRNA
(always referred to as ssRNA) was transcribed by cores
[20]. After transcription, the cores were pelleted at 10,000
g; the supernatant, which contained the ssRNA was then
made 0.5% with respect to sodium dodecyl sulfate (SDS)
and extracted three times with phenol/chloroform. The
RNA was precipitated with Polyethylene glycol (PEG),
reextracted three times with penol/chloroform, and pre-
cipitated with 2.5 M ammonium acetate and ethanol.
ssRNA prepared in this manner contained no residual
infectious virus. For all lipofections, we used 10 µl of Rab-
bit Reticulocyte Lysate (Promega #L4960) primed with
0.3–0.5 µg of ST3 ssRNA (obtained from in vitro tran-
scription from reovirus cores) and 0.1 µg of the indicated
s2 ssRNA (obtained from in vitro transcription using T7
RNA polymerase and the indicated cDNA template,
Promega- RiboMAX™-T7) in 1 µl H2O and 12 units of
RNasin® Plus RNase Inhibitor (Promega) in 1 µl H2O.
Translation was allowed to proceed for 1 hour at 30 C.
After translation, an additional 0.3–0.5 µg of ST3 ssRNA
in 1 µl H2O was added and the mixture was immediately
added to 0.5 ml of MEM containing penicillin and strep-
tomycin and 50 µl of Lipofectin® (Invitrogen Corpora-
tion). This mixture was immediately added to PBS-
washed monolayers of 106 mouse L929 fibroblasts in 6-
well multiplates. After 6 hr, this mixture was replaced with
0.25 ml of MEM containing 4 × 107 PFU of ST2 reovirus,
and 1 hr later 1.75 ml of MEM containing 5% fetal bovine
serum was added. After 24 hr, the cells were harvested,
washed twice in MEM, and sonicated in 2 ml of MEM, and
virus in the sonicates was titrated in mouse L929 fibrob-
last monolayers. To avoid detection of the ST2 helper
virus, plaques were counted on day 5, when plaques
formed by ST2 virus were not yet detectable.
Virus titration/determination of CAT activity
Monolayers of lipofected and infected L-ST3.S2 cells were
incubated at 37° for five days. Neutral red was added 24
hours before counting plaques [10,12]. CAT activity in cell
lysates was assayed using CAT ELISA (Boehringer Man-
nheim Corporation). We measure the CAT activity of our
engineered viruses as a method to screen large numbers of
recombinant viruses when we encounter ssRNAs that are
inefficiently incorporated in progeny viruses. Although
useful this activity is not used to confirm that we have gen-
erated a recombinant virus. The CAT activity is low as it is
expressed as a σ2-CAT fusion protein. The S2 dsRNA of all
recombinant viruses is sequenced to confirm the presence
of the S20CAT genome segment and it exact nucleotide
sequence.
Detection of reovirus s2 ssRNA in vivo
Twelve hours following lipofection of L929 or L-ST3.S2
cells with the indicated ssRNAs, protein translation mix-
ture, and infection with reovirus serotype 2 helper virus,
total RNA was extracted from the cell monolayers using
Eppendorfs' Perfect RNA™ Eukaryotic Mini kit and proto-
cols. The ssRNA was electrophoresed in a formaldehyde
denaturing gel using Ambion, Inc's NorthernMax ® kit.
Following the manufacturer's protocol, the ssRNA was
transferred to a BrightStar ®-Plus Positively Charged Nylon
Membrane and UV-cross linked. Hybridization/detection
was carried out at 40 C according to manufacturer's direc-
tions using UltrahybTM buffer and 32P-labelled oligonu-
cleotides. For detecting the ST3 s2 ssRNA, the
oligonucleotide (S2.5)
5'CAAACCACCAGACGTTTTACACGGTTAATTGCTGCTT
GATA3' complementary to nucleotides 55 to 95 near the 5'
end of the s2 RNA was used. For detecting the s2/CAT
ssRNA, the oligonucleotide (CAT.1)
5'TTTACGATGCCATTGGGATATATCGGTGGTATATCC3'
complementary to CAT gene was used. The oligonucle-
otide S2.5 was selected because it is 19.5% mismatchedVirology Journal 2006, 3:1 http://www.virologyj.com/content/3/1/1
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with the ST2 s2 sequence and, when used as a ssRNA
probe, does not detect the ST2 s2 ssRNA or the S2 dsRNA
genome segment. The membrane was used to expose x-ray
film.
Detection of reovirus s2 and CAT/s2 dsRNA in vivo
Twelve hours following lipofection of L929 or L-ST3.S2
cells with the indicated ssRNAs, protein translation mix-
ture, and infection with reovirus serotype 2 helper virus,
total cell monolayers were harvested. The dsRNA was elec-
trophoresed in 7.5% SDS-PAGE gels for 2650 volt/hours
as described (16). Following the protocol used for the
ssRNA gels, the dsRNA was transferred to a BrightStar®-
Plus Positively Charged Nylon Membrane and UV-cross
linked. Hybridization/detection was carried out at 40 C
according to manufacturer's directions, using UltrahybTM
buffer and 32P-labelled oligonucleotides. For detecting the
ST3 s2 dsRNA, the oligonucleotide S2.5 was used as
described above. For detecting the s2/CAT ssRNA, the oli-
gonucleotide CAT.1 complementary to CAT gene was
used. The membrane was used to expose x-ray film.
Recombinant virus purification
Forty-eight hours following lipofection of L929 or L-
ST3.S2 cells with the indicated ssRNAs, protein transla-
tion mixture, and infection with reovirus serotype 2
helper virus, total cell monolayers were harvested. Serial
10-fold dilutions were prepared from these lysates and
monolayers of L929 or L-ST3.S2 cells were infected. After
incubation at 37° for five days, neutral red was added 24
hours before counting plaques [10,12]. Visualized
plaques were selected using Pasteur pipettes and placed in
1 ml MEM w/o serum. Serial 10-fold dilutions were pre-
pared from these individual virus isolates and monolayers
of L929 or L-ST3.S2 cells were infected. After incubation at
37° for five days, neutral red was added 24 hours before
counting plaques [10,12]. Visualized plaques were
selected using Pasteur pipettes and placed in 1 ml MEM w/
o serum. This plaque-purification process was repeated a
third time. The dsRNA genomes of each three-time
plaque-purified isolate were then analyzed by SDS-PAGE.
In summary, individual wells of 96 well plates of L929 or
L-ST3.S2 cells were infected with 50 µl of each isolate.
After incubation at 37 C for 24 hours, 1 µCi 32P ortho-
phosphate was added to each well. After an additional 24
hours, 50 µl 2X Laemmli sample buffer was added to each
well and the plates stored at -20 C. The plates were heated
to 65 C for 10 minutes and 10 µl of each well loaded onto
a 7.5% SDS-PAGE gel and electrophoresis carried out for
2650 volt/hours. The gels were immediately dried and
used to expose X-ray film. For recombinant viruses that
should have the CAT gene expressed in frame, CAT activity
was checked as an additional screen, and all recombinant
reoviruses were identified by sequencing of the engi-
neered S2 dsRNA to confirm that the engineered ssRNA
made in vitro had been incorporated as constructed.
Sequencing of cDNA templates and recombinant viruses
All cDNA templates were sequenced to confirm the pres-
ence of the desired mutations. The T7-generated ssRNAs
were sequenced using two methods: the 5' 200 nucle-
otides sequenced using reverse transcriptase (RT) and a
complementary primer, the 3' ends first poly-A tailed
using yeast poly-A polymerase, then sequenced using RT
and an oligo-T primer, as described [10,12,21]. Following
purification, all recombinant reoviruses were propagated
and the S2 dsRNA genome segments sequenced directly
using reverse transcriptase as described [21].
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